To assess the applicability of the P450 inhibition assay in PD diagnosis, it was necessary to determine if this assay has the ability to distinguish other neurodegenerative diseases, such as AD, and inflammatory-associated diseases, such as T2D. Here, CYP2B6 is linked to Parkinson disease.